SYK - Educational Analysis * US Equities
Educational Analysis * US Equities

SYK

Earnings behavior, post-earnings drift, and the gap between consensus and the market's real expectation - the educational primer before you look at the institutional verdict.

Educational content only - not investment advice. Nothing on this page is a recommendation to buy or sell any security. Historical patterns do not predict future outcomes. Consult a licensed financial advisor before making any trading decision.
Published byGamma QC editorial
TickerSYK
CategoryEducational primer
Last reviewedAugust 3, 2026
You're viewing an older edition of this page.Read the latest edition →

How SYK Has Traded Around Earnings

Stryker (SYK), a Healthcare/Medical - Devices name, reports earnings on a well-defined cadence, and the last eight quarters show a clear statistical fingerprint. The company beat the consensus in seven of those eight releases, an 88% beat rate, with an average earnings surprise of 1.3%. That headline consistency, however, does not translate into a reliable post-release rally. Across the same eight quarters, the average 5-day price move in the five trading days after earnings was -2.82%, with the drift direction classified as “down.”

The most recent releases illustrate the divergence between the EPS result and the price reaction. On 2026-07-30, SYK reported actual EPS of $3.69 against an estimate of $3.49, a 5.7% surprise and a clear beat, yet the stock fell -6.42% the next day and posted 0% over the following five days. On 2026-01-29, a smaller beat—actual EPS $4.47 versus estimate $4.4, a 1.6% surprise—produced a positive reaction of +4.31% the next day and +2.29% over the next five sessions. By contrast, 2025-10-30 delivered a 1.9% beat ($3.19 vs. $3.13 estimate) but the stock dropped -3.45% the next day and -4.11% over five days. The only outright miss in this window, 2026-04-30 (actual EPS $2.60 vs. estimate $2.98, a -12.8% surprise), sparked a -6.47% next-day decline and a -6.63% five-day drift. The takeaway is that the directional move is only partly explained by whether the printed number is above or below the consensus.

Options-Flow Dynamics Before the Oct. 29 Report

The next scheduled earnings release is 2026-10-29 after the close, with the consensus EPS estimate at $3.57. Around that date, options markets normally reprice implied volatility, with the event-week premium typically reflecting the expected one-day and multi-day move. Given SYK’s recent history of single-session post-earnings moves ranging from -6.47% to +4.31%, the options chain is likely to price a meaningful expected move into the October expiry. A trader can infer the market’s real expectation by comparing the at-the-money straddle price to the magnitude of those historical moves and to the -2.82% average five-day drift.

Beyond implied volatility levels, flow dynamics include call-versus-put skew and whether open interest is building in upside or downside strikes ahead of the report. If call premium becomes unusually rich relative to puts, it can signal positioning for an upside reaction; heavy put flow may simply hedge against the down-drift tendency. After the announcement, implied volatility typically compresses regardless of direction, so the embedded expected move matters at least as much as the binary beat-or-miss outcome.

What a Disciplined Trader Watches Now

With SYK at $335.57, an RSI of 52.2, and the 50-day EMA at $323.04, the immediate technical backdrop is neutral heading into the 2026-10-29 report. The disciplined read combines the 88% beat rate and the 1.3% average surprise with the -2.82% average five-day drift. That combination says beats are common, but follow-through has been weak or negative, so price reaction may depend more on guidance, margins, or macro tone than on the EPS print alone.

A risk framework might use the historical one-day moves as a gauge for position sizing: the Apr. 30 miss showed a -6.47% next-day drop, while the Jan. 29 beat produced a +4.31% next-day gain. The 50-day EMA at $323.04 is a reference level in any post-earnings gap scenario. For the deeper directional context, look at the full institutional verdict to see how sell-side estimates and positioning line up against the numbers above.

Frequently Asked Questions

What is SYK's earnings beat rate and average surprise over the last eight quarters?

Over the last eight reported quarters, SYK beat the consensus in seven of eight releases, an 88% beat rate, with an average earnings surprise of 1.3%.

How has SYK's stock performed in the five trading days after earnings?

The average 5-day price move in the five trading days after earnings across those quarters was -2.82%, classified as a down drift. For example, after the 2026-04-30 miss the stock fell -6.63% over five days, while after the 2026-01-29 beat it rose +2.29% over five days.

When does SYK report next and what is the consensus EPS estimate?

SYK’s next scheduled earnings release is 2026-10-29 after the close, with a consensus EPS estimate of $3.57. The current snapshot shows SYK at $335.57, an RSI of 52.2, and the 50-day EMA at $323.04.

Real Data - Gamma QC Earnings IntelligenceAs of Aug 3, 2026
Stryker Corporation · Healthcare / Medical - Devices
$128.6BMarket cap
34.5P/E
14.4%Net margin
16.4%ROE
88%Beat rate, last 8Q
1.3%Avg EPS surprise
-2.82%Avg 5-day move after earnings
2026-10-29Next earnings
ReportedActualEstimateSurprise1D Move5D Move
2026-07-30$3.69$3.49+5.7%-6.42%null%
2026-04-30$2.6$2.98-12.8%-6.47%-6.63%
2026-01-29$4.47$4.4+1.6%+4.31%+2.29%
2025-10-30$3.19$3.13+1.9%-3.45%-4.11%
2025-07-31$3.13$3.07+2%--
2025-05-01$2.84$2.71+4.8%--

Previous SYK editions

Beyond the primer

Get the institutional verdict on SYK

Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.

Read the SYK verdict at Gamma QC
$49 Pro / $249 RIA * gammaqc.com

Verify authenticity

Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.